HDR has been selected to support the Washington State Department of Ecology in developing a programmatic environmental impact statement, or PEIS, to prepare for development of green hydrogen energy projects… Read More
VANCOUVER, BC – Filament Health Corp. (OTCQB:FLHLF) (NEO:FH) (FSE:7QS) (“Filament” or the “Company”), a clinical‐stage natural psychedelic drug development company, announced that the Business Combination Agreement, by and among the Company, Jupiter Acquisition… Read More
LAVAL, QC – Bausch Health, Canada, part of Bausch Health Companies Inc. (NYSE: BHC) (TSX: BHC), (“Bausch Health” or the “Company”) announced that DUOBRII™ (0.01% w/w halobetasol propionate and 0.045%… Read More
OTTAWA, ON – Canadians should be able to appropriately access and afford the prescription drugs they need. However, many Canadians are left vulnerable due to high drug costs, inaccessible health… Read More
VANCOUVER, BC — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, announced it is expected to be added to the Nasdaq Biotechnology Index (Nasdaq: NBI) (the… Read More
